Prescription drug · ANDA
Hydralazine Hydrochloride NDC 63187-901
Hydralazine hydrochloride 25 mg/1 · Tablet, Film coated · Oral · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 63187-901-30 | 63187090130 | 30 TABLET, FILM COATED in 1 BOTTLE (63187-901-30)Marketed from Sep 1, 2017 | |
| 63187-901-60 | 63187090160 | 60 TABLET, FILM COATED in 1 BOTTLE (63187-901-60)Marketed from Sep 1, 2017 | |
| 63187-901-90 | 63187090190 | 90 TABLET, FILM COATED in 1 BOTTLE (63187-901-90)Marketed from Sep 1, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Hydralazine Hydrochloride
- Generic name (nonproprietary)
- hydralazine hydrochloride
- Active ingredients
- Hydralazine hydrochloride — 25 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Proficient Rx LP
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 086242
- Marketing start
- Listing expires
- Other FDA classes
- Arteriolar Vasodilation (Physiologic effect)
- Identifiers
- Product ID 63187-901_8abc5903-cbd2-436d-b229-4e76d3726e09SPL ID 8abc5903-cbd2-436d-b229-4e76d3726e09SPL set ID 63f388e0-9f3d-4902-990c-9a105aa098adRxCUI 905225UNII FD171B778Y
- Pharmacologic class
- Arteriolar Vasodilator
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N463187090130followed by a unit qualifier and the quantityPackage 63187-0901-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Essential hypertension, alone or as an adjunct.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 086242
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Hydralazine Hydrochloride | Hydralazine hydrochloride 25 mg/1 | Tablet, Film coatedOral | Chartwell RX, LLC | 62135-580 |
| Hydralazine Hydrochloride | Hydralazine hydrochloride 10 mg/1 | Tablet, Film coatedOral | Chartwell RX, LLC | 62135-579 |
| Hydralazine Hydrochloride | Hydralazine hydrochloride 50 mg/1 | Tablet, Film coatedOral | Chartwell RX, LLC | 62135-581 |
| Hydralazine Hydrochloride | Hydralazine hydrochloride 100 mg/1 | Tablet, Film coatedOral | Chartwell RX, LLC | 62135-582 |
| Hydralazine Hydrochloride | Hydralazine hydrochloride 50 mg/1 | Tablet, Film coatedOral | PD-Rx Pharmaceuticals, Inc. | 43063-392 |
| Hydralazine Hydrochloride | Hydralazine hydrochloride 50 mg/1 | Tablet, Film coatedOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-003 |